CFTR and cystic fibrosis: In other words, pharmacological therapy with CFTR modulators does not interfere with the delicate balance of CFTR-mediated secretion and absorption of ASL and will probably remain more efficacious in real life for the CF patient community than any of the ongoing ambitious attempts to correct the CFTR gene, transcript, or protein (20).